Table 4.
Clinical features of patients in different ALL groups before chemotherapy
| Clinical features | ALL | ||
|---|---|---|---|
| Newly Diagnosed | CR | Refractory & Relapsed | |
| Sex | |||
| Male | 50 | 24 | 26 |
| Female | 34 | 20 | 19 |
| Age (year) | 31 (18-77) | 29 (18-62) | 27 (18-77) |
| WBC (×109/L) | 53 (0.9-367.4) | 14.75 (3.01-39.65) | 25.99 (0.45-102.56) |
| Hb (g/L) | 70 (31-143) | 108 (84-394) | 75 (48-139) |
| PLT(×109/L) | 37(1-338) | 105 (25-394) | 45 (2-245) |
| Subtype | T 14 | T 4 | T 4 |
| B 70 | B 40 | B 41 | |
| Chromosome Abnormality | Ph + 20 | Ph + 6 | Ph + 10 |
| del (5) (p14) 2 | 21 + mar 1 | del (5) (p14) 1 | |
| 21 + mar 2 | |||
| Molecular Genetics Abnormality | bcr-abl 20 | bcr-abl 6 | bcr-abl 10 |
| Sternal tenderness | 54/84 | 20/44 | 27/45 |
| Lymphadenectasis | 50/84 | 25/44 | 26/45 |
| Splenohepatomegalia | 45/84 | 21/44 | 23/45 |
| Curative effect | 69/84 | 44/44 | 36/45 |
This table shows clinical features of ALL patients in different groups at the time of diagnosis. WBC: White blood cell; Hb: Hemoglobin; PLT: Platelet. Curative effect refers to achieving complete remission after 2 courses of standard chemotherapy.